Traditional Chinese Medicine-based Treatment in Cardiovascular Disease: Potential Mechanisms of Action

Overview

Journal Curr Pharm Biotechnol

Publisher Bentham Science Publishers

Specialties Biotechnology
Pharmacology

Date 2024 Feb 13

PMID 38347793

Authors

Lanlan Li

Yutong Ran

Jiao Wen

Yirui Lu

Shunmei Liu

Hong Li

Min Cheng

Affiliations

Soon will be listed here.

Abstract

Cardiovascular Disease (CVD) is the leading cause of morbidity and death worldwide and has become a global public health problem. Traditional Chinese medicine (TCM) has been used in China to treat CVD and achieved promising results. Therefore, TCM has aroused significant interest among pharmacologists and medical practitioners. Previous research showed that TCM can regulate the occurrence and development of atherosclerosis (AS), ischemic heart disease, heart failure, myocardial injury, and myocardial fibrosis by inhibiting vascular endothelial injury, inflammation, oxidant stress, ischemia-reperfusion injury, and myocardial remodeling. It is well-known that TCM has the characteristics of multi-component, multi-pathway, and multitarget. Here, we systematically review the bioactive components, pharmacological effects, and clinical application of TCM in preventing and treating CVD.

Citing Articles

Chinese and western medicine treatment of myocardial fibrosis drugs.

Zhu Y, Zhang F, Li Z, Zhou Y, Shu Y, Ruan J Front Cardiovasc Med. 2025; 11:1477601.

PMID: 39882321 PMC: 11774883. DOI: 10.3389/fcvm.2024.1477601.

References

Wang T, Wu Z, Sun L, Li W, Liu G, Tang Y . A Computational Systems Pharmacology Approach to Investigate Molecular Mechanisms of Herbal Formula Tian-Ma-Gou-Teng-Yin for Treatment of Alzheimer's Disease. Front Pharmacol. 2018; 9:668. PMC: 6028720. DOI: 10.3389/fphar.2018.00668. View

Man B, Hu C, Yang G, Xiang J, Yang S, Ma C . Berberine attenuates diabetic atherosclerosis via enhancing the interplay between KLF16 and PPARα in ApoE mice. Biochem Biophys Res Commun. 2022; 624:59-67. DOI: 10.1016/j.bbrc.2022.07.072. View

Mannino F, Pallio G, Altavilla D, Squadrito F, Vermiglio G, Bitto A . Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet. Biomolecules. 2022; 12(7). PMC: 9313394. DOI: 10.3390/biom12070973. View

Ni Y, Zhang J, Zhu W, Duan Y, Bai H, Luan C . Echinacoside inhibited cardiomyocyte pyroptosis and improved heart function of HF rats induced by isoproterenol via suppressing NADPH/ROS/ER stress. J Cell Mol Med. 2022; 26(21):5414-5425. PMC: 9639035. DOI: 10.1111/jcmm.17564. View

Yang Q, Xu Y, Shen L, Pan Y, Huang J, Ma Q . Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet. J Immunol Res. 2022; 2022:7128230. PMC: 9352486. DOI: 10.1155/2022/7128230. View

Jiang Q, Chen X, Tian X, Zhang J, Xue S, Jiang Y . Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway. Phytomedicine. 2022; 106:154439. DOI: 10.1016/j.phymed.2022.154439. View

Liu Y, Yang G, Huo S, Wu J, Ren P, Cao Y . Lutein suppresses ferroptosis of cardiac microvascular endothelial cells via positive regulation of IRF in cardiac hypertrophy. Eur J Pharmacol. 2023; 959:176081. DOI: 10.1016/j.ejphar.2023.176081. View

Jiaying Z, Xiangxiang W, Xuefeng L, Yang Y, Yinghuan D, Yanbin S . Shunxin decoction improves diastolic function in rats with heart failure with preserved ejection fraction induced by abdominal aorta constriction through cyclic guanosine monophosphate-dependent protein kinase Signaling Pathway. J Tradit Chin Med. 2022; 42(5):764-772. PMC: 9924685. DOI: 10.19852/j.cnki.jtcm.20220519.003. View

Kotlyarov S . Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis. Genes (Basel). 2022; 13(8). PMC: 9408222. DOI: 10.3390/genes13081474. View

10.

Hansson G, Libby P . The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006; 6(7):508-19. DOI: 10.1038/nri1882. View

11.

Yu B, Zhao S, Huang X . Oxidized low-density lipoprotein: a double-edged sword on atherosclerosis. Med Hypotheses. 2007; 69(3):553-6. DOI: 10.1016/j.mehy.2007.01.043. View

12.

Han X, Wang S, Yang X, Li T, Zhao H, Zhou L . Analysis of plasma migration components in Patrinia villosa (Thunb.) Juss. effective parts by UPLC-Q-TOF-MS. Biomed Chromatogr. 2019; 34(1):e4701. DOI: 10.1002/bmc.4701. View

13.

Zhang A, Ma Z, Kong L, Gao H, Sun H, Wang X . High-throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai-Xin-San against APP/PS1 transgenic mice based on UPLC-Q/TOF-MS. Biomed Chromatogr. 2019; 34(2):e4724. DOI: 10.1002/bmc.4724. View

14.

Simayi J, Abulizi A, Nuermaimaiti M, Khan N, Hailati S, Han M . UHPLC-Q-TOF-MS/MS and Network Pharmacology Analysis to Reveal Quality Markers of Xinjiang Mill. for Antiatherosclerosis. Biomed Res Int. 2022; 2022:4176235. PMC: 9167097. DOI: 10.1155/2022/4176235. View

15.

Bi Y, Han X, Lai Y, Fu Y, Li K, Zhang W . Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis. J Ethnopharmacol. 2021; 278:114278. DOI: 10.1016/j.jep.2021.114278. View

16.

Li X, Liu S, Qu L, Chen Y, Yuan C, Qin A . Dioscin and diosgenin: Insights into their potential protective effects in cardiac diseases. J Ethnopharmacol. 2021; 274:114018. DOI: 10.1016/j.jep.2021.114018. View

17.

Liang J, Li W, Liu H, Li X, Yuan C, Zou W . Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway. Front Pharmacol. 2022; 13:857092. PMC: 9096164. DOI: 10.3389/fphar.2022.857092. View

18.

Liang P, Chen X, Gong M, Xu Y, Tu H, Zhang L . Guang Chen Pi (the pericarp of Citrus reticulata Blanco's cultivars 'Chachi') inhibits macrophage-derived foam cell formation. J Ethnopharmacol. 2022; 293:115328. DOI: 10.1016/j.jep.2022.115328. View

19.

Boezio B, Audouze K, Ducrot P, Taboureau O . Network-based Approaches in Pharmacology. Mol Inform. 2017; 36(10). DOI: 10.1002/minf.201700048. View

20.

Torres P, Sodero A, Jofily P, Silva-Jr F . Key Topics in Molecular Docking for Drug Design. Int J Mol Sci. 2019; 20(18). PMC: 6769580. DOI: 10.3390/ijms20184574. View